CardiAxis Medical Inc.

CardiAxis Medical designs and develops SHARP-VT, a treatment planning platform that integrates multi-modal imaging data (CT, MRI, nuclear imaging, electrical mapping) for cardiac radioablation (RA), a novel non-invasive treatment of arrhythmias. By streamlining and standardizing treatment plans, CardiAxis Medical are enabling RA to be used in routine clinical care. SHARP-VT reduces inter-physician variability and reduces case planning duration from several hours to ~15 minutes, evidenced by use in over 30 prospective clinical cases and ongoing validation in a randomized trial.